| A Long-term Efficacy and Safety of NTQ5082 Capsules (NCT07177872) | Nanjing Chia-tai Tianqing Pharmaceutical | 2026-06-01 |
| A Phase III Clinical Trial of NTQ1062 in Combination With Fulvestrant for the Treatment of Advanced or Metastatic HR+/HER2- Breast Cancer (NCT07393321) | Nanjing Chia-tai Tianqing Pharmaceutical | 2026-02-10 |
| A Phase III Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients (NCT07177859) | Nanjing Chia-tai Tianqing Pharmaceutical | 2025-11-01 |
| Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Injection (NCT06977763) | Nanjing Chia-tai Tianqing Pharmaceutical | 2025-07-01 |
| Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics of NTB003 in Healthy Participants (NCT07182552) | Nanjing Chia-tai Tianqing Pharmaceutical | 2025-06-30 |
| Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA Nephropathy (NCT06982040) | Nanjing Chia-tai Tianqing Pharmaceutical | 2025-05-01 |
| Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Electrolyte Sodium Acetate Injection (NCT06977750) | Nanjing Chia-tai Tianqing Pharmaceutical | 2025-04-27 |
| A Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients (NCT06764303) | Nanjing Chia-tai Tianqing Pharmaceutical | 2025-01-23 |
| A Study of Ramelteon in Chinese Patients With Chronic Insomnia (NCT06512363) | Nanjing Chia-tai Tianqing Pharmaceutical | 2024-08-01 |
| Effect of Food of NTQ5082 in Healthy Subjects (NCT06558656) | Nanjing Chia-tai Tianqing Pharmaceutical | 2024-08-01 |
| A Phase 1 Clinical Trial of NTQ5082 in Healthy Volunteers (NCT06560593) | Nanjing Chia-tai Tianqing Pharmaceutical | 2024-08-01 |
| A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer (NCT06172322) | Nanjing Chia-tai Tianqing Pharmaceutical | 2023-12-28 |
| A Clinical Trial to Evaluate Efficacy and Safety of Elagolix Tablets in Women With Moderate or Severe Endometriosis-associated Pain (NCT06076486) | Nanjing Chia-tai Tianqing Pharmaceutical | 2023-09-14 |
| A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies (NCT06049667) | Nanjing Chia-tai Tianqing Pharmaceutical | 2023-08-07 |
| A Phase I Study of NTQ1062 in Chinese Patients With Advanced Solid Tumors (NCT06172309) | Nanjing Chia-tai Tianqing Pharmaceutical | 2021-09-24 |
| Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis (NCT05450887) | Nanjing Chia-tai Tianqing Pharmaceutical | 2021-09-23 |